Bacil Pharma Ltd. Share Price & Stock Analysis

Bacil Pharma Limited develops, manufactures, and distributes pharmaceuticals products in India. The company offers tablets, capsules, injectables, ointments, and specialty products. Bacil Pharma Limited was incorporated in 1987 and is based in Mumbai, India.

Key Metrics

Current Price	₹38.38
Market Cap	₹54 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products
P/E Ratio	34.6
52-Week Range	₹26.69 – ₹61.80
Beta (1Y)	0.35

Peer Companies

• Sanofi Consumer Healthcare India Ltd
• ASTONEA LABS LIMITED
• Goldline Pharmaceutical Limite
• Venmax Drugs And Pharmaceuticals Ltd
• Jfl Life Sciences Limited
• RUBICON RESEARCH LIMITED
• Sunrest Lifescience Limited
• Valiant Laboratories Limited

Frequently Asked Questions

What is the current share price of Bacil Pharma Ltd.?

Bacil Pharma Ltd. is trading at ₹38.38, with a market capitalisation of ₹54 Cr.

Which sector does Bacil Pharma Ltd. belong to?

Bacil Pharma Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products).

What are the key financial ratios of Bacil Pharma Ltd.?

Bacil Pharma Ltd. has a P/E of 34.6.